Journal of Cell Biology 2000-10-30

Evidence for segregation of sphingomyelin and cholesterol during formation of COPI-coated vesicles.

B Brügger, R Sandhoff, S Wegehingel, K Gorgas, J Malsam, J B Helms, W D Lehmann, W Nickel, F T Wieland

Index: J. Cell Biol. 151 , 507-18, (2000)

Full Text: HTML

Abstract

In higher eukaryotes, phospholipid and cholesterol synthesis occurs mainly in the endoplasmic reticulum, whereas sphingomyelin and higher glycosphingolipids are synthesized in the Golgi apparatus. Lipids like cholesterol and sphingomyelin are gradually enriched along the secretory pathway, with their highest concentration at the plasma membrane. How a cell succeeds in maintaining organelle-specific lipid compositions, despite a steady flow of incoming and outgoing transport carriers along the secretory pathway, is not yet clear. Transport and sorting along the secretory pathway of both proteins and most lipids are thought to be mediated by vesicular transport, with coat protein I (COPI) vesicles operating in the early secretory pathway. Although the protein constituents of these transport intermediates are characterized in great detail, much less is known about their lipid content. Using nano-electrospray ionization tandem mass spectrometry for quantitative lipid analysis of COPI-coated vesicles and their parental Golgi membranes, we find only low amounts of sphingomyelin and cholesterol in COPI-coated vesicles compared with their donor Golgi membranes, providing evidence for a significant segregation from COPI vesicles of these lipids. In addition, our data indicate a sorting of individual sphingomyelin molecular species. The possible molecular mechanisms underlying this segregation, as well as implications on COPI function, are discussed.


Related Compounds

Related Articles:

Lipidomic analyses of female mice lacking hepatic lipase and endothelial lipase indicate selective modulation of plasma lipid species.

2014-06-01

[Lipids 49(6) , 505-15, (2014)]

Relating toxicity to transfection: using sphingosine to maintain prolonged expression in vitro.

2015-01-05

[Mol. Pharm. 12(1) , 264-73, (2015)]

More Articles...